Review Finds Little Evidence that Electroconvulsive Therapy is Effective for Depression

21
Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.

Review Questions Long Term Use of Antipsychotics

14
Patients who recover from a single episode of psychosis are often prescribed antipsychotics long-term, despite a lack of evidence for this practice

The ADHD Drug Epidemic: Addiction, Abuse, and Death

18
A new analysis of FDA data, published on September 10th by the Milwaukee Journal Sentinel/MedPage Today, reveals the dangers of the common prescription of...

Psychiatric Diagnosis Can Lead to Epistemic Injustice, Researchers Claim

6
A discussion of the role of epistemic injustice in the experiences of patients diagnosed with psychiatric disorders.

After the Black-Box: Majority of Children Starting SSRIs Still Receiving Too High of Dose

19
In 2004, the FDA added a black-box warning to SSRI antidepressants on the increased risk of suicide among children taking these drugs. A new study suggests that this warning has increased the proportion of children who begin an antidepressant on a low dose, but the majority are still receiving higher than recommended doses.

FDA Warns About New Impulse-Control Problems Associated With Abilify

39
Yesterday, the US Food and Drug Administration (FDA) released a warning that the antipsychotic drug aripiprazole or Abilify is associated with compulsive and uncontrollable...

Study Explores Cognitive Effects of Antipsychotics

15
Reduced usage of antipsychotics in first-episode psychosis was associated with improved executive functioning.

Rethinking Madness and Medication: Researcher Discusses Psychiatric Drug Withdrawal and Survivor Movements

29
New understandings of medication and withdrawal experiences warrant rethinking conceptualizations of health and ā€œmadness."

ā€œThe Rise and Fall of the Blockbuster Antipsychotic Seroquelā€

4
Martha Rosenberg highlights how the popular antipsychotic Seroquel is a perfect example of how direct-to-consumer advertising made billion dollar blockbuster drugs possible before side-effects...

About 1 in 100 Children Treated with Ritalin Experience a Serious Adverse Event

6
A recent Cochrane review has found that serious adverse events occur for about 1% of children and adolescents treated with Ritalin.

Antidepressant to Blame for Frank Sinatra’s Failing Health

1
FromĀ Fox News: According to Frank Sinatra's manager Eliot Weisman, Sinatra suffered from several adverse effects of the antidepressant Elavil during his final years. "...there was...

People Diagnosed with Bipolar Disorder at Increased Risk for Parkinson’s

18
Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.

ADHD Drugs Linked to Psychotic Symptoms in Children

3
Stimulant medications like Ritalin and Adderall, often prescribed to treat children diagnosed with ADHD, are known to cause hallucinations and psychotic symptoms. Until recently these adverse effects were considered to be rare. A new study to be published in the January issue of Pediatrics challenges this belief, however, and finds that many more children may be experiencing psychotic symptoms as a result of these drugs than previously acknowledged.

The ADHD Drug Abuse Crisis on College Campuses

14
The abuse of ADHD drugs on college campuses has reached epidemic proportions, according to the authors of a recent review in the journal of Ethical Human Psychology and Psychiatry. ADHD drugs, like Ritalin and Adderall, have become so commonplace on college campuses that students abusing these drugs for studying, weight loss and partying have underestimated their risks. As a result, we have seen exponential increases in emergency room visits, overdoses, and suicides by students taking these drugs.

Cymbalta Withdrawal Lawsuit Moves Forward

5
The warning label for the antidepressant Cymbalta downplayed the risks of withdrawal effects, according to consumer lawsuits being filed in courts across the country. ā€œAn estimated 44% to 78% of people who stop taking Cymbalta (also known as duloxetine) will suffer from withdrawal reactions,ā€ yet the warning label ā€œsuggests the risk is greater than or equal to 1%.ā€

Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities

16
One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

Study Finds High Risk for Suicide Following Psychiatric Hospitalization

12
Patients are at an increased risk for suicide during the three months immediately following discharge from an inpatient psychiatric hospital.

Going Off My Meds Gave Me Rage Attacks

1
In this piece forĀ Glamour, Suzannah Weiss tells her story of SSRI withdrawal, which resulted in intense rage attacks for six months after discontinuation and...

Physicians Underestimate Harms and Overestimate Benefits of Treatment

7
A new study analyzed over 13,000 doctors and found that physicians had a poor understanding of risks and benefits in every field, including psychopharmaceutical prescription, to CT scans, and cancer screening.

Criticism of Coercion and Forced Treatment in Psychiatry

12
A recent editorial, published in BMJ, argues there is an increase in coercive measures in psychiatry that are damaging to individuals diagnosed with mental illness.

Study Connects Environmental Risk Factors and Psychosis

4
A meta-analysis of known risk factors for psychosis finds elevated risk with the presence of childhood trauma, adverse life events, and affective dysfunction.

Critiques of a New Research Study on Antidepressants

5
A new meta-analysisĀ claimingĀ to prove once and for all that antidepressants areĀ an effective treatment for moderate to severe depression was published just a few days...

Interview: Researchers Deconstruct Ghostwritten Industry Trial for Antidepressant

3
Researchers, Jon Jureidini, Jay Amsterdam and Leemon McHenry, have taken a closer look at the data from a randomized control trial of citalopram (Celexa) that was ghostwritten and then used by the manufacturers to support claims of the drug’s efficacy and safety in the treatment of child and adolescent depression. To get the background on this story, we connected with Dr. Leemon McHenry, an investigator in this study and a lecturer in philosophy at California State University, Northridge.

Amphetamines Have Long-Term Effects on Adolescent Brain, Study Finds

13
A new study published in the journal Neuroscience finds that rats given regular doses of amphetamines during adolescence haveĀ brain and behavioral changes in adulthood....

The Impact of Mindfulness on Mental Health Stigma Resistance

51
A new study examines the association of mindfulness and stigma resistance among individuals with a psychiatric diagnosis.